Agios Pharmaceuticals
AGIO
AGIO
168 hedge funds and large institutions have $1.64B invested in Agios Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.84% less ownership
Funds ownership: 107.58% → 105.74% (-1.8%)
44% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $18.9M
Holders
168
Holding in Top 10
–
Calls
$10.6M
Puts
$18.9M
Top Buyers
| 1 | +$54.4M | |
| 2 | +$23.7M | |
| 3 | +$22M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$7.25M |
| 5 |
Axa
Paris,
France
|
+$4.66M |
Top Sellers
| 1 | -$38.5M | |
| 2 | -$30.3M | |
| 3 | -$29.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$21.7M |
| 5 |
CC
Casdin Capital
New York
|
-$17.4M |